Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01172145 · ClinicalTrials.gov registry record · Phase 3
Treatment of Apathy in Alzheimer's Disease With Modafinil
A Phase 3 study, sponsored by Brown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 22
- Enrollment target
NCT01172145 is a Phase 3 study that has completed, run by Brown University. The registered enrollment target is 22 participants.
The verdict
NCT01172145, a Phase 3 study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).
Interventions
- DRUG Placebo
- DRUG Modafinil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01172145
The ClinicalTrials.gov registry entry for NCT01172145 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brown University, which has 231 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01172145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01172145 about?
NCT01172145 is a clinical study titled "Treatment of Apathy in Alzheimer's Disease With Modafinil". This study examined the effects of modafinil on apathetic symptomatology, performance of activities of daily living (ADLs) and caregiver burden in individuals with Alzheimer's disease (AD).
What is the current status of trial NCT01172145?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 22 participants. The study started on 2005-07. Estimated completion is 2007-09.
What interventions are being tested in trial NCT01172145?
The interventions under investigation include: Placebo (DRUG), Modafinil (DRUG).
Who is sponsoring clinical trial NCT01172145?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.